Combined Use of a Novel Cardioplegic Formula With Myocardial Protection System (MPS)® Versus Cardioplexol ® in Isolated Coronary Artery Bypass Grafting (CABG) Using MiECC;

Study at a glance

From the registry record, last updated by the sponsor on 31 Jul 2019. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title

Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Isolated CABG Using MiECC (Minimal Extracorporeal Circulation System)

ClinicalTrials.gov ID

NCT03612388

Acronym / sponsor ID

MiECC / 2018-00926; ch18Reuthebuch3

Conditions

Complication of Extracorporeal Circulation, Complication of Coronary Artery Bypass Graft

Study type

Observational

Recruitment status

Completed

Enrolment

211 participants (actual)

Lead sponsor

University Hospital, Basel, SwitzerlandUniversity, hospital or other

Study start

28 Feb 2010 (actual)

Primary completion

31 Mar 2018 (actual)

Study completion

13 Mar 2019 (actual)

First posted

2 Aug 2018 (actual)

Results

Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Study design

Observational model

Cohort

Time perspective

Prospective

Number of arms

2

Who may qualify

Sex

All

Healthy volunteers

Not accepted

Age groups

Child, Adult, Older adult

Study population

Patients undergoing isolated CABG (coronary artery bypass grafting) using MiECC (Minimal extracorporeal circulation system) at the department of cardial surgery University Hospital Basel Switzerland

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Primary outcome

1. Change in lab values for cardial biomarkers

   Time frame: perioperative during hospital stay for CABG

   cardial biomarkers measured are high sensitive troponin T (hs-TrT), Creatinkinase, (CK) Creatinkinase myocardial type (CK-MB)

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

• Official record on ClinicalTrials.govLast updated by the sponsor 31 Jul 2019.

Related trials for Complication of Extracorporeal Circulation

• RecruitingObservational study

  Observational Study of Platelet Dysfunction Assessed by Thromboelastography in Cardiovascular Surgery (DISPLATEG)

  Blood Platelet Disorders, Cardiac Surgery

• Active, not recruitingObservational study

  Effect of Minimally Invasive Extracorporeal Circulation on Optic Nerve Sheath Diameter and Stroke Incidence in Isolated Open Heart Surgery

  Stroke, Cardiac Surgery

• Active, not recruitingPhase 3

  Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation

  Scheduled Cardiac Surgery With Extracorporeal Circulation, Vasoplegic Syndrome

• RecruitingObservational study

  Evaluation of Blood and Cardiac Protein O-GlcNAcylation Levels in Cardiac Surgery in Children

  Cardiac Surgery, Extracorporeal Circulation; Complications

• RecruitingObservational study

  A Monitoring System Based on the Multifactorial Dynamic Perfusion Index to Predict and Prevent the Onset of Postoperative Acute Kidney Injury After Cardiac Surgery, Based on a Dynamic Collection of Hemodynamic and Clinical Parameters During Cardiopulmonary Bypass

  Cardiac Diseases, Cardio-pulmonary Bypass

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

1 site in 1 country: see every site and its status.